These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30259646)

  • 21. Revesz syndrome revisited.
    Karremann M; Neumaier-Probst E; Schlichtenbrede F; Beier F; Brümmendorf TH; Cremer FW; Bader P; Dürken M
    Orphanet J Rare Dis; 2020 Oct; 15(1):299. PubMed ID: 33097095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progresses in studies on allogeneic hematopoietic stem cell transplantation in children with acquired severe aplastic anemia].
    Liu TF; Zhu XF
    Zhonghua Er Ke Za Zhi; 2013 May; 51(5):345-8. PubMed ID: 23941840
    [No Abstract]   [Full Text] [Related]  

  • 23. Allo-SCT in a patient with CRMCC with aplastic anemia using a reduced intensity conditioning regimen.
    Asai D; Osone S; Imamura T; Sakaguchi H; Nishio N; Kuroda H; Kojima S; Hosoi H
    Bone Marrow Transplant; 2012 Aug; 47(8):1126-7. PubMed ID: 22080964
    [No Abstract]   [Full Text] [Related]  

  • 24. Revesz syndrome masquerading as traumatic retinal detachment.
    Moussa K; Huang JN; Moore AT
    J AAPOS; 2017 Oct; 21(5):422-425.e1. PubMed ID: 28866069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconsidering the indication of haematopoietic stem cell transplantation for dyskeratosis congenita.
    Kojima S; Ehlert K
    Br J Haematol; 2018 Oct; 183(1):11-12. PubMed ID: 29978455
    [No Abstract]   [Full Text] [Related]  

  • 26. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bone marrow failure due to telomere associated gene mutation].
    Yamaguchi H; Dan K
    Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
    [No Abstract]   [Full Text] [Related]  

  • 28. Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature.
    Barbaro P; Vedi A
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1152-1158. PubMed ID: 26968789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts.
    Sorge C; Pereboeva L; Westin E; Harris WT; Kelly DR; Goldman F
    Bone Marrow Transplant; 2017 May; 52(5):765-768. PubMed ID: 28092351
    [No Abstract]   [Full Text] [Related]  

  • 30. Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation.
    Sørensen CD; Møller BK; Olesen G; Hokland P; Hokland M
    Bone Marrow Transplant; 2018 Dec; 53(12):1578-1582. PubMed ID: 29884849
    [No Abstract]   [Full Text] [Related]  

  • 31. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.
    Ghavamzadeh A; Alimoghadam K; Nasseri P; Jahani M; Khodabandeh A; Ghahremani G
    Bone Marrow Transplant; 1999 Feb; 23(3):299-301. PubMed ID: 10084264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications for a Hoyeraal-Hreidarsson Syndrome Patient with a Germline
    Chen RL; Lin KK; Chen LY
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.
    Vigouroux S; Tabrizi R; Melot C; Coiffard J; Lafarge X; Marit G; Bouabdallah K; Pigneux A; Leguay T; Dilhuydy MS; Schmitt A; Boiron JM; Milpied N
    Leuk Lymphoma; 2012 Jan; 53(1):162-5. PubMed ID: 21756024
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.
    Vuong LG; Hemmati PG; Neuburger S; Terwey TH; Vulliamy T; Dokal I; le Coutre P; Dörken B; Arnold R
    Acta Haematol; 2010; 124(4):200-3. PubMed ID: 21042011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyskeratosis Congenita.
    Stoopler ET; Shanti RM
    Mayo Clin Proc; 2019 Sep; 94(9):1668-1669. PubMed ID: 31486376
    [No Abstract]   [Full Text] [Related]  

  • 36. RETINAL VASCULAR TORTUOSITY AND EXUDATIVE RETINOPATHY IN A FAMILY WITH DYSKERATOSIS CONGENITA MASQUERADING AS FAMILIAL EXUDATIVE VITREORETINOPATHY.
    Thanos A; Todorich B; Hypes SM; Yonekawa Y; Thomas B; Randhawa S; Drenser KA; Trese MT
    Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S187-S190. PubMed ID: 27685501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wanted: prospective studies of alternative donors.
    Brunstein CG
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):957-8. PubMed ID: 25889041
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Kawamata T; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1150-5. PubMed ID: 24727335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan.
    Amarasinghe K; Dalley C; Dokal I; Laurie A; Gupta V; Marsh J
    Bone Marrow Transplant; 2007 Nov; 40(9):913-4. PubMed ID: 17724438
    [No Abstract]   [Full Text] [Related]  

  • 40. In celebration of Ruggero Ceppellini: HLA in transplantation.
    Petersdorf EW
    HLA; 2017 Feb; 89(2):71-76. PubMed ID: 28102037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.